Sulforaphane (1-isothiocyanato-4-methylsulfinylbutane) is a potent compound found in cruciferous vegetables, particularly broccoli and broccoli sprouts.
Recognized for its chemoprotective properties, sulforaphane is formed when the enzyme myrosinase hydrolyzes glucoraphanin.
This compound selectively induces phase 2 detoxification enzymes, such as quinone reductase and glutathione S-transferases, without affecting phase 1 enzymes, thereby protecting against carcinogens and toxic electrophiles.
Sulforaphane's broad protective effects, including cancer prevention, inflammation reduction, and detoxification of harmful substances, are primarily due to its action on the Nrf2-Keap1 signaling pathway.
This enhances the body's defense mechanisms, offering benefits in cancer, neurodegenerative diseases, cardiovascular diseases, and diabetes.
Research demonstrates sulforaphane's efficacy in various cancer models, highlighting its mechanisms of cell cycle arrest, apoptosis induction, and modulation of xenobiotic metabolism enzymes.
Sulforaphane (1-isothiocyanato-4-methylsulfinylbutane) is a potent isothiocyanate found in cruciferous vegetables, particularly broccoli and broccoli sprouts. It is recognized for its chemoprotective properties [5., 18.].
This compound is formed when the enzyme myrosinase hydrolyzes glucoraphanin, its glucosinolate precursor [15.].
Sulforaphane acts as a powerful selective inducer of phase 2 detoxification enzymes like quinone reductase and glutathione S-transferases without affecting phase I enzymes; these phase II enzymes protect against carcinogens and toxic electrophiles [3., 18.].
Sulforaphane exhibits broad protective effects, from cancer prevention to reducing inflammation and detoxifying harmful substances like air pollutants [15.].
Many of its wide-reaching health benefits are due to its effects on the Nrf2-Keap1 signaling pathway, enhancing the body's defense mechanisms to provide benefit in cancer, neurodegenerative and cardiovascular diseases, and diabetes [17.].
Research has demonstrated sulforaphane's efficacy in various cancer models, including cell cultures, animal studies, and early-stage clinical trials [3.]. Its mechanisms of action include cell cycle arrest, apoptosis induction, and modulation of enzymes involved in xenobiotic metabolism [3.].
Cruciferous vegetables, particularly broccoli, are the primary dietary sources of sulforaphane [5., 6., 18.].
Other sources include Brussels sprouts, cabbage, cauliflower, kale, and mustard greens. The sulforaphane content in these vegetables can vary depending on factors such as cultivar, growing conditions, and post-harvest handling [6., 14.].
Remarkably, 3-day-old broccoli sprouts contain 10-100 times more glucoraphanin (the precursor to sulforaphane) than mature plants [5.].
In humans, the bioavailability and efficacy of sulforaphane depend on factors such as the method of consumption (raw vs. cooked) and individual differences in gut microbiota and genetic polymorphisms in detoxifying enzymes [3.].
Research indicates that cooking methods significantly impact the bioavailability of sulforaphane from cruciferous vegetables. Raw or lightly cooked broccoli yields higher sulforaphane bioavailability (37%) compared to fully cooked broccoli (3.4%) [12.].
Microwaving broccoli for 2 minutes results in approximately 3-fold higher sulforaphane production in vivo compared to 5.5 minutes of cooking [8.].
Commercial blanching-freezing processes destroy myrosinase activity, reducing sulforaphane bioavailability by about tenfold compared to fresh broccoli [10.].
Sulforaphane is rapidly absorbed and metabolized, with metabolites excreted within 72 hours [3.].
Sulforaphane has been extensively studied for its potential health benefits, including:
Sulforaphane has been shown to induce apoptosis (programmed cell death) in cancer cells and inhibit tumor growth and metastasis.
Sulforaphane exerts its anti-cancer properties through multiple mechanisms, including epigenetic regulation, cell cycle modulation, apoptosis induction, and inflammation reduction [1., 3., 11.].
Studies have demonstrated Sulforaphane's potential in reducing the risk of breast, prostate, lung, colon, stomach, and bladder cancers [1., 4., 17.].
Sulforaphane exhibits antioxidant activity by inducing the expression of antioxidant enzymes and reducing oxidative stress. It also possesses anti-inflammatory properties by inhibiting the production of inflammatory mediators.
Sulforaphane enhances the body's antioxidant capacity by activating the Nrf2-Keap1 signaling pathway, which induces the expression of cytoprotective genes that detoxify electrophiles and maintain redox homeostasis [17.].
Additionally, Sulforaphane reduces inflammation by modulating key enzymes and signaling pathways, including the inhibition of NF-κB activity, which plays a central role in inflammatory responses [17.].
Sulforaphane has shown promising neuroprotective effects, particularly against neurodegenerative diseases such as Alzheimer's, Parkinson's, and multiple sclerosis [2.].
Sulforaphane's primary mechanism involves the activation of the Nrf2 pathway, which enhances antioxidant defenses and reduces inflammation and apoptosis [2., 17.].
Studies have demonstrated that Sulforaphane can improve neuronal viability, reduce oxidative stress, and inhibit the formation of amyloid-beta plaques in Alzheimer's disease, protect dopaminergic neurons in Parkinson's disease, and preserve the integrity of the blood-brain barrier in multiple sclerosis [2., 19.].
Sulforaphane improves cholinergic neurotransmission by increasing acetylcholine levels and reducing acetylcholinesterase activity, which also helps in managing Alzheimer's disease symptoms [19.].
Sulforaphane's antioxidant and anti-inflammatory properties contribute to its cardioprotective effects, potentially reducing the risk of cardiovascular diseases [19.].
Sulforaphane provides significant cardioprotective benefits through various mechanisms.
It reduces oxidative stress by enhancing the expression and activity of antioxidant enzymes such as superoxide dismutase (SOD) and glutathione, primarily through the activation of the Nrf2 pathway [19.].
This action helps prevent lipid peroxidation and lowers reactive oxygen species (ROS) levels.
Additionally, sulforaphane suppresses inflammation by modulating the NF-κB pathway, which reduces the expression of pro-inflammatory cytokines and adhesion molecules, thereby preventing vascular inflammation and endothelial cell injury [17., 19.].
It also decreases inflammatory markers like TNF-α and IL-1β [19.].
Sulforaphane inhibits apoptosis in cardiomyocytes by modulating the mitochondrial apoptotic pathway and reducing the expression of pro-apoptotic factors [3., 19.].
Moreover, it regulates lipid metabolism by decreasing serum lipids, improving lipid profiles by increasing HDL-C levels, and reducing atherosclerosis through the inhibition of monocyte binding to endothelial cells and suppression of atherosclerotic plaque formation [19.].
Finally, sulforaphane lowers blood pressure, reduces blood glucose levels, and improves insulin sensitivity, making it beneficial for managing diabetes and metabolic syndrome [19.].
Sulforaphane shows promising benefits in treating and reducing diabetes risk.
It activates Nrf2 and modulates AMPK, protecting against diabetic complications like cardiomyopathy, neuropathy, and nephropathy [7.].
Sulforaphane exhibits antioxidant and anti-inflammatory properties, potentially reducing cardiovascular disease risk in type 2 diabetes patients [7., 16.].
It inhibits advanced glycation end product formation and suppresses AGE-induced inflammatory reactions [16.].
Sulforaphane demonstrates antidiabetic and anti-obesity effects, improving glucose tolerance and reducing fat accumulation [2.].
It enhances insulin sensitivity, increases glucose transporter activity, and promotes lipid metabolism, primarily through Nrf2 pathway regulation [13., 19.].
Additionally, sulforaphane shows potential in treating various diabetes-related complications by acting on multiple molecular targets in different organs [13.].
Sulforaphane has shown promise as a chemopreventive agent as well as a neuroprotective and cardiometabolic protective agent, and a potent anti-inflammatory compound in various studies.
It acts primarily by inducing the NRF2 pathway, which regulates cellular redox homeostasis and detoxification [15.].
Clinical trials have explored sulforaphane's potential in treating multiple diseases, with biomarkers focused on NRF2 target gene expression, inflammation, and oxidative stress [15.].
Increasingly, laboratory companies strive to determine the most effective ways to demonstrate cellular health. Assessing an individual’s cellular resistance to oxidative stress is a valuable descriptor for overall cellular health and may shed light on cancer and cardiometabolic protection status.
Some companies are exploring new ways to assess cellular health by understanding an individual’s cellular resistance to oxidative stress. This can be assessed in blood, which requires a venipuncture for sample collection.
Special preparation such as fasting may be required; it is essential to consult with the ordering provider prior to sample collection.
For more information on this type of testing, click here.
Sulforaphane confers multiple benefits to promote cellular health and protect against oxidative stress.
One laboratory company utilizes whole blood samples to assess an individual’s resistance to oxidative stress. They report optimal levels as being >/= 120% protection against oxidative stress. [9.].
A high level of sulforaphane confers increased cellular protection against oxidative stress.
Low levels of sulforaphane may indicate an increased susceptibility to cellular oxidative stress.
Click here to compare testing options and order testing to assess cellular antioxidant status.
[1.] Atwell LL, Beaver LM, Shannon J, Williams DE, Dashwood RH, Ho E. Epigenetic Regulation by Sulforaphane: Opportunities for Breast and Prostate Cancer Chemoprevention. Current Pharmacology Reports. 2015;1(2):102-111. doi:https://doi.org/10.1007/s40495-014-0002-x
[2.] Baralić K, Jovana Živanović, Đurđica Marić, et al. Sulforaphane—A Compound with Potential Health Benefits for Disease Prevention and Treatment: Insights from Pharmacological and Toxicological Experimental Studies. Antioxidants. 2024;13(2):147-147. doi:https://doi.org/10.3390/antiox13020147
[3.] Clarke JD, Dashwood RH, Ho E. Multi-targeted prevention of cancer by sulforaphane. Cancer letters. 2008;269(2):291-304. doi:https://doi.org/10.1016/j.canlet.2008.04.018
[4.] Djaldetti M. Sulforaphane: The Principal Broccoli Phytochemical as a Cancer Challenger. Recent Progress in Nutrition. 2022;2(1):1-1. doi:https://doi.org/10.21926/rpn.2201008
[5.] Fahey JW, Zhang Y, Talalay P. Broccoli sprouts: An exceptionally rich source of inducers of enzymes that protect against chemical carcinogens. Proceedings of the National Academy of Sciences. 1997;94(19):10367-10372. doi:https://doi.org/10.1073/pnas.94.19.10367
[6.] Kushad MM, Brown AF, Kurilich AC, et al. Variation of Glucosinolates in Vegetable Crops of Brassica oleracea. Journal of Agricultural and Food Chemistry. 1999;47(4):1541-1548. doi:https://doi.org/10.1021/jf980985s
[7.] Mthembu SXH, Mazibuko-Mbeje SE, Moetlediwa MT, et al. Sulforaphane: A nutraceutical against diabetes-related complications. Pharmacological Research. 2023;196:106918. doi:https://doi.org/10.1016/j.phrs.2023.106918
[8.] Rungapamestry V, Duncan AJ, Fuller Z, Ratcliffe B. Effect of meal composition and cooking duration on the fate of sulforaphane following consumption of broccoli by healthy human subjects. British Journal of Nutrition. 2007;97(4):644-652. doi:https://doi.org/10.1017/s0007114507381403
[9.] Rupa Health. Redox Antioxidant Protection Assay Sample Report.pdf. Google Docs. https://drive.google.com/file/d/1Nvm-8KOPTK2InJyjT8cvdv1m9aaDh6MV/view
[10.] Saha S, Hollands W, Teucher B, et al. Isothiocyanate concentrations and interconversion of sulforaphane to erucin in human subjects after consumption of commercial frozen broccoli compared to fresh broccoli. Molecular Nutrition & Food Research. 2012;56(12):1906-1916. doi:https://doi.org/10.1002/mnfr.201200225
[11.] Ullah M. Sulforaphane (Sulforaphane): An Isothiocyanate in a Cancer Chemoprevention Paradigm. Medicines. 2015;2(3):141-156. doi:https://doi.org/10.3390/medicines2030141
[12.] Vermeulen M, Klöpping-Ketelaars IWAA, van den Berg R, Vaes WHJ. Bioavailability and kinetics of sulforaphane in humans after consumption of cooked versus raw broccoli. Journal of Agricultural and Food Chemistry. 2008;56(22):10505-10509. doi:https://doi.org/10.1021/jf801989e
[13.] Wang M, Chen M, Guo R, Ding Y, Zhang H, He Y. The improvement of sulforaphane in type 2 diabetes mellitus (T2DM) and related complications: A review. Trends in Food Science & Technology. 2022;129:397-407. doi:https://doi.org/10.1016/j.tifs.2022.10.007
[14.] West LG, Meyer KA, Balch BA, Rossi FJ, Schultz MR, Haas GW. Glucoraphanin and 4-Hydroxyglucobrassicin Contents in Seeds of 59 Cultivars of Broccoli, Raab, Kohlrabi, Radish, Cauliflower, Brussels Sprouts, Kale, and Cabbage. Journal of Agricultural and Food Chemistry. 2004;52(4):916-926. doi:https://doi.org/10.1021/jf0307189
[15.] Yagishita Y, Fahey JW, Dinkova-Kostova AT, Kensler TW. Broccoli or Sulforaphane: Is It the Source or Dose That Matters? Molecules. 2019;24(19). doi:https://doi.org/10.3390/molecules24193593
[16.] Yamagishi SI, Matsui T. Protective role of sulphoraphane against vascular complications in diabetes. Pharmaceutical Biology. 2016;54(10):2329-2339. doi:https://doi.org/10.3109/13880209.2016.1138314
[17.] Yang L, Palliyaguru DL, Kensler TW. Frugal chemoprevention: targeting Nrf2 with foods rich in sulforaphane. Seminars in Oncology. 2016;43(1):146-153. doi:https://doi.org/10.1053/j.seminoncol.2015.09.013
[18.] Zhang Y, Talalay P, Cho CG, Posner GH. A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure. Proceedings of the National Academy of Sciences. 1992;89(6):2399-2403. doi:https://doi.org/10.1073/pnas.89.6.2399
[19.] Kamal RM, Abdull Razis AF, Mohd Sukri NS, et al. Beneficial Health Effects of Glucosinolates-Derived Isothiocyanates on Cardiovascular and Neurodegenerative Diseases. Molecules. 2022;27(3):624. doi:https://doi.org/10.3390/molecules27030624